Vortioxetine for Posttraumatic Stress Disorder

Completed · Phase 4 · Has a placebo group

Conditions studied: Post-Traumatic Stress Disorder

In brief

Post-traumatic stress disorder (PTSD) can result from having experienced or witnessed a traumatic event. Patients with PTSD symptoms can sometimes experience symptom relief after treatment with antidepressants; however, few patients experience complete symptom relief. There is a need to develop new treatments for PTSD. This study will evaluate if 12 weeks of using Vortioxetine relieves PTSD symptoms. Vortioxetine has been approved for the treatment of depression; however, Vortioxetine has not been approved by the Food and Drug Administration for the treatment of PTSD.

Key facts

Study ID
NCT02637895
Run by
University of Miami
People needed
41
Starts
2016-12-01
Expected to finish
2020-02-06
Last updated by the study team
2021-02-08

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.